Justin Stebbing, Editor-in-Chief of Oncogene and Professor of Biomedical Sciences at Anglia Ruskin University, shared a post on LinkedIn about a paper he co-authored with colleagues published in Oncogene:
“A remarkable case report I was lucky enough to be involved in, a complete response in late-line testicular cancer, using salvage therapy with iNKT cells, a new form of off-the-shelf cell therapy.”
Title: Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumor
Authors: Benjamin Garmezy, Joseph E. Grossman, Jennifer Buell, Thiago Favano, Justin Stebbing, Steven O’Day, Marco A. Purbhoo, Dhan Chand, F. Anthony Greco
You can read the Full Article in Oncogene.
More posts featuring Justin Stebbing.
